MM Brands Expands Mary’s Medicinals and DIXIE Across California

Mary’s Medicinals and DIXIE are entering a new phase of California growth, supported by manufacturing and distribution infrastructure, retailer-focused execution, and the equity of two established cannabis brands.

MM Brands, the parent company of Mary’s Medicinals and DIXIE, has entered a strategic partnership with StateHouse Holdings to expand both brands in California. Under the agreement, StateHouse licensed subsidiaries will assume manufacturing and distribution for both brands in the state, using StateHouse’s vertically integrated California platform to scale production, improve distribution, and widen retail access. MM Brands will remain focused on brand development, product innovation, retailer support, education, and consumer demand, while StateHouse and distribution partner Nabis strengthen local execution. The goal is straightforward: make two recognized legacy cannabis brands easier for California retailers to stock and sell, and easier for patients and adult-use consumers to find and trust.

“Our strategy at MM Brands extends well beyond returning products to retail shelves. We are building enduring, category-leading brands by aligning the right products with the right market partners and creating compelling value for patients, consumers, and retailers. Our partnerships with StateHouse and NABIS reflect this long-term vision and represent a significant milestone in the continued growth and expansion of the Mary’s Medicinals and DIXIE brands. Together, these relationships strengthen our distribution platform, expand market access, and position our brands for sustained success in an increasingly competitive marketplace,” said Joe Bayern, CEO of MM Brands.

What the California Partnership Covers

The partnership assigns the core California manufacturing and distribution responsibilities for Mary’s Medicinals and DIXIE to StateHouse licensed subsidiaries. StateHouse operates cultivation, processing, manufacturing, distribution, and retail assets in California, giving the partnership an established operational base inside the state rather than a strategy built around brand licensing alone.

The distinction matters. California is not one uniform retail market. The buying dynamics of Los Angeles, the Bay Area, Sacramento, San Diego, the Central Coast, and inland communities can differ materially. A brand seeking statewide relevance needs dependable production, compliant distribution, inventory visibility, responsive account service, retail relationships, and local market knowledge. The partnership is structured to bring those pieces together around two brands with existing consumer awareness.

StateHouse CEO Jim Scott described the strategic fit in direct terms: “This partnership brings together two organizations with highly complementary strengths. MM Brands has a clear vision for Mary’s & DIXIE, their innovation and long-term brand development, while StateHouse brings deep California market expertise and operational capabilities. That alignment gives us confidence in the opportunity ahead.”

The announcement also identifies NABIS as a key distribution partner supporting the broader California execution strategy. In practical terms, the combination is intended to let each organization stay focused on its strongest role: MM Brands on brand leadership and innovation, StateHouse on licensed in-state operations, and NABIS on distribution reach and market connectivity.

Why Mary’s Medicinals and DIXIE Still Carry Weight

Mary’s Medicinals and DIXIE enter this partnership with different product identities, but both bring the kind of history that cannot be fabricated with a launch campaign. Mary’s Medicinals is recognized for its pioneering patented transdermal delivery technology and wellness-focused cannabis formulations. DIXIE is a bonafide iconic / legacy brand in cannabis edibles, with longstanding recognition among adult-use consumers.

Kavi Bhai, CFO at StateHouse, emphasized the strategic value of Mary’s position: “What makes Mary’s compelling is that it brings more than just brand awareness. It has a clear point of differentiation, a loyal following and products that consumers recognize immediately. From our perspective, that makes Mary’s a very strong strategic fit for the StateHouse platform and a brand we believe has meaningful room to grow.”

Mary’s Medicinals Enters From a Position of Strength

Mary’s Medicinals is not rebuilding from zero in California. According to current company and NABIS platform data supplied for this story, the brand is active in more than 400 California retail accounts and ranks among the top five brands on the California NABIS Marketplace.

That footprint matters because it shows the brand already has meaningful retailer access and an established base from which to grow. The opportunity is to turn existing recognition and account penetration into more consistent availability, stronger retail support, and sustained consumer demand across the state.

California Cannabis Success Requires Local Execution

California remains one of the world’s most influential cannabis markets, but influence does not make it simple. The state’s scale magnifies every operational weak point. A delay at manufacturing can become an inventory gap across multiple regions. A distribution issue can leave retailers without expected products. Inconsistent education can weaken recommendations at the point of sale. When those problems compound, even a well-known brand can lose relevance quickly.

Patrick Larkin, Chief Commercial Officer at MM Brands, framed the challenge this way: “California is one of the most important cannabis markets in the world, and for both Mary’s Medicinals and DIXIE to succeed here requires far more than strong brand recognition. It demands exceptional retail execution, trusted distribution partners, and experienced teams with deep local market expertise. StateHouse and NABIS provide the infrastructure, operational excellence, and market reach needed to execute at the highest level, allowing our team to remain focused on what we do best: building our brands, supporting retail partners, driving consumer demand, and delivering innovative products that patients and consumers trust and love.”

What the Partnership Means for California Cannabis Retailers

Retail adoption is where the strategy will ultimately be tested. California dispensaries do not need another brand asking for shelf space without a plan for sell-through. They need products with a clear customer, a defensible point of difference, dependable fulfillment, relevant education, and responsive support.

For Mary’s Medicinals, the opportunity centers on differentiated wellness products and transdermal delivery formats that can serve both patients & consumers seeking options beyond conventional inhalable or edible categories. For DIXIE, established awareness in cannabis edibles can help retailers meet demand for familiar, approachable product formats. In both cases, brand history gives retail teams a story to tell, but the partnership’s job is to provide the inventory and support that make the story commercially useful.

Larkin said retailer usability is one of the partnership’s central priorities: “One of our highest priorities is making both Mary’s Medicinals and DIXIE easier for retailers to stock, recommend, and sell, and in doing so, easier for consumers to rediscover and trust. Achieving that requires more than great products. It demands unwavering quality, reliable inventory management, a thoughtfully curated brand portfolio, continued product innovation, comprehensive education, and consistent field support. Our partnerships with StateHouse and NABIS bring all of those elements together, creating a stronger foundation for execution in California and positioning both brands for long-term, sustainable growth.”

What California Patients and Adult-Use Consumers Can Expect

For consumers, the intended outcome is improved access to recognizable products backed by more consistent California execution. Mary’s Medicinals is expected to continue leaning into science, wellness, and differentiated delivery systems. DIXIE brings an established position in edibles and an identity built over years in the regulated cannabis category.

Because cannabis inventory can vary by store and region, consumers should check licensed dispensary menus and official brand channels for current Mary’s Medicinals and DIXIE availability near them. As manufacturing and distribution scale, the meaningful measure will be whether shoppers across California markets can locate products reliably, understand what differentiates them, and return to the same trusted experience.

The Bottom Line

The strategic partnership between MM Brands and StateHouse Holdings creates a California operating foundation for Mary’s Medicinals and DIXIE that combines brand leadership with local manufacturing, distribution, and retail execution. Supported by the companies’ relationship with Nabis, the model is designed to increase statewide access while improving the fundamentals that matter to retailers and consumers: quality, inventory reliability, education, field support, and consistent product availability.

If the partnership delivers on those fundamentals, it can do more than return two recognized cannabis names to additional shelves. It can show how legacy brand equity, paired with disciplined local operations, can still create meaningful growth in California’s demanding regulated market.

Learn more about MM Brands and its portfolio at www.mmbrandsinc.com. California consumers and retailers should consult official brand resources and licensed dispensary menus for current Mary’s Medicinals and DIXIE product availability.

Frequently Asked Questions

---